{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:08:02Z","timestamp":1782860882398,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/Aim<\/jats:title>\n                    <jats:p>Achieving negative margins while ensuring a safe reconstruction is known to be challenging in junctional tumors involving both the stomach and the distal esophagus. When a gastric conduit or a transhiatal Roux limb is precluded, a transthoracic long Roux limb reconstruction offers an alternative. Open approaches have traditionally carried high morbidity rates, but advances in minimally invasive surgery could possibly mitigate these limitations. The primary aim of this study was to assess the feasibility and safety of a fully robotic approach in a highly selected patient population treated in a specialized surgical setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All fully robotic extended total gastrectomies with transthoracic long Roux limb reconstruction performed at the ZGT Hospital in Almelo, The Netherlands, were extracted from a prospective registry. Data were summarized in tables. Means and medians were calculated as appropriate. Survival was calculated by means of Kaplan\u2013Meier analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-three patients were included, most with cT3\u20134N\u2009+\u2009tumors and unfavorable histology. Major complications (Clavien\u2013Dindo\u2009\u2265\u20093) occurred in five (22%), and anastomotic leaks in two (8.7%) patients. Thirty- and 90-day mortality rates were 0% and 9%, respectively. Mean operative time was 7\u00a0h, with median ICU and hospital stays of 1 and 9\u00a0days, respectively. The mean lymph node yield was 26.5. There were five (22%) R1 resections, all of which had diffuse histology and intraoperative endoscopic as well as pathological assessment. The median overall and disease-free survival was 13.1 and 6.4\u00a0months, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Outcomes indicate that the technique is feasible and safe, possibly offering favorable recovery compared to traditional open methods. Oncologic outcomes are reported descriptively and should be interpreted in the context of advanced disease stage and unfavorable tumor biology. A relatively high rate of R1 resections was observed, highlighting the challenges in the represented cancer subtypes rather than procedural deficits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00464-026-12745-1","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:46:26Z","timestamp":1773852386000},"page":"3555-3562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fully robotic extended total gastrectomy with transthoracic long Roux limb reconstruction"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-8740","authenticated-orcid":false,"given":"Adam","family":"Zeyara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"van Det","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Badaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle P.","family":"Ruurda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk-Jan T. J.","family":"Mantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewout A.","family":"Kouwenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"12745_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjtc.2025.05.020","author":"M Sewell","year":"2025","unstructured":"Sewell M, Sihag S, Bott MJ et al (2025) Supradiaphragmatic Roux-en-Y jejunal reconstruction after extended total gastrectomy for gastroesophageal adenocarcinoma. JTCVS Tech. https:\/\/doi.org\/10.1016\/j.xjtc.2025.05.020","journal-title":"JTCVS Tech"},{"key":"12745_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-020-07152-1","author":"JM Leers","year":"2020","unstructured":"Leers JM, Knepper L, Van Der Veen A et al (2020) The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II. BMC Cancer. https:\/\/doi.org\/10.1186\/S12885-020-07152-1","journal-title":"BMC Cancer"},{"key":"12745_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/S12893-023-02072-W","author":"R Jiang","year":"2023","unstructured":"Jiang R, Wang Y, Xu J, Chen Z, Pang L (2023) Reconstruction using the colon or jejunum in patients with synchronous advanced esophageal and gastric cancers: a retrospective study from a single institutional database. BMC Surg. https:\/\/doi.org\/10.1186\/S12893-023-02072-W","journal-title":"BMC Surg"},{"issue":"8","key":"12745_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11748-016-0661-0","volume":"64","author":"M Watanabe","year":"2016","unstructured":"Watanabe M, Mine S, Nishida K, Kurogochi T, Okamura A, Imamura Y (2016) Reconstruction after esophagectomy for esophageal cancer patients with a history of gastrectomy. Gen Thorac Cardiovasc Surg 64(8):457\u2013463. https:\/\/doi.org\/10.1007\/s11748-016-0661-0","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"12745_CR5","doi-asserted-by":"publisher","DOI":"10.3978\/J.ISSN.2072-1439.2014.05.07","author":"P Gaur","year":"2014","unstructured":"Gaur P, Blackmon SH (2014) Jejunal graft conduits after esophagectomy. J Thorac Dis. https:\/\/doi.org\/10.3978\/J.ISSN.2072-1439.2014.05.07","journal-title":"J Thorac Dis"},{"issue":"5","key":"12745_CR6","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jtcvs.2005.06.032","volume":"130","author":"AJ Ascioti","year":"2005","unstructured":"Ascioti AJ, Hofstetter WL, Miller MJ et al (2005) Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 130(5):1391\u20131398. https:\/\/doi.org\/10.1016\/j.jtcvs.2005.06.032","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"12745_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.surge.2014.01.004","volume":"13","author":"CR Baker","year":"2015","unstructured":"Baker CR, Forshaw MJ, Gossage JA, Ng R, Mason RC (2015) Long-term outcome and quality of life after supercharged jejunal interposition for oesophageal replacement. Surgeon 13(4):187\u2013193. https:\/\/doi.org\/10.1016\/j.surge.2014.01.004","journal-title":"Surgeon"},{"issue":"4","key":"12745_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.athoracsur.2012.05.123","volume":"94","author":"SH Blackmon","year":"2012","unstructured":"Blackmon SH, Correa AM, Skoracki R et al (2012) Supercharged pedicled jejunal interposition for esophageal replacement: a 10-year experience. Ann Thorac Surg 94(4):1104\u20131113. https:\/\/doi.org\/10.1016\/j.athoracsur.2012.05.123","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"12745_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.surg.2009.10.045","volume":"147","author":"CD Klink","year":"2010","unstructured":"Klink CD, Binneb\u00f6sel M, Schneider M, Ophoff K, Schumpelick V, Jansen M (2010) Operative outcome of colon interposition in the treatment of esophageal cancer: a 20-year experience. Surgery 147(4):491\u2013496. https:\/\/doi.org\/10.1016\/j.surg.2009.10.045","journal-title":"Surgery"},{"issue":"3","key":"12745_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1053\/J.OPTECHSTCVS.2006.08.003","volume":"11","author":"SR DeMeester","year":"2006","unstructured":"DeMeester SR (2006) Colonic interposition for benign disease. Oper Tech Thorac Cardiovasc Surg 11(3):232\u2013249. https:\/\/doi.org\/10.1053\/J.OPTECHSTCVS.2006.08.003","journal-title":"Oper Tech Thorac Cardiovasc Surg"},{"issue":"1","key":"12745_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12893-020-00810-Y\/FIGURES\/4","volume":"20","author":"S Jiang","year":"2020","unstructured":"Jiang S, Guo C, Zou B et al (2020) Comparison of outcomes of pedicled jejunal and colonic conduit for esophageal reconstruction. BMC Surg 20(1):1\u201310. https:\/\/doi.org\/10.1186\/S12893-020-00810-Y\/FIGURES\/4","journal-title":"BMC Surg"},{"issue":"2","key":"12745_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/J.1442-2050.2007.00738.X","volume":"21","author":"Y Doki","year":"2008","unstructured":"Doki Y, Okada K, Miyata H et al (2008) Long-term and short-term evaluation of esophageal reconstruction using the colon or the jejunum in esophageal cancer patients after gastrectomy. Dis Esophagus 21(2):132\u2013138. https:\/\/doi.org\/10.1111\/J.1442-2050.2007.00738.X","journal-title":"Dis Esophagus"},{"key":"12745_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-019-5922-8","author":"WH Han","year":"2019","unstructured":"Han WH, Eom BW, Yoon HM et al (2019) The optimal extent of lymph node dissection in gastroesophageal junctional cancer: retrospective case control study. BMC Cancer. https:\/\/doi.org\/10.1186\/S12885-019-5922-8","journal-title":"BMC Cancer"},{"issue":"10","key":"12745_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110342","volume":"51","author":"L Triemstra","year":"2025","unstructured":"Triemstra L, de Jongh C, Brenkman HJF et al (2025) Implementing robot-assisted minimally invasive gastrectomy (RAMIG) for gastric cancer in a European tertiary referral center. Eur J Surg Oncol 51(10):110342. https:\/\/doi.org\/10.1016\/j.ejso.2025.110342","journal-title":"Eur J Surg Oncol"},{"key":"12745_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.amjsurg.2018.11.049","volume":"218","author":"M Jeremiasen","year":"2019","unstructured":"Jeremiasen M, Walther B, Djerf P et al (2019) Thoracoabdominal gastrectomy and distal 2\/3 esophageal resection with wide lymph node dissection for type II and III adenocarcinoma at the gastro-esophageal junction. Am J Surg 218:329\u2013334. https:\/\/doi.org\/10.1016\/j.amjsurg.2018.11.049","journal-title":"Am J Surg"},{"issue":"10184","key":"12745_CR16","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet 393(10184):1948\u20131957. https:\/\/doi.org\/10.1016\/S0140-6736(18)32557-1","journal-title":"Lancet"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-12745-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-12745-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-12745-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:37:47Z","timestamp":1782859067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-026-12745-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["12745"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-12745-1","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MvD, JR, and EK declare that they have advisory roles for Intuitive Surgical Int. The remaining authors have declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This retrospective observational cohort study was conducted in accordance with the Declaration of Helsinki. It was approved by ZGT in Almelo, The Netherlands, and the requirement for individual informed consent was waived because of the retrospective and solely observational design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}